预康复中随机对照试验的报告质量:一个范围审查
Dominique Engel1,2, Giuseppe Dario Testa2,3, Daniel I McIsaac4
1Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Perioperative medicine (London, England)
|August 31, 2023
概括
在预康复随机对照试验 (RCT) 中,报告质量低于最佳,仅报告了约一半的推清单项目. 制定预康复干预措施的具体报告清单可以提高研究透明度和一致性.
科学领域:
- 医学研究方法论医学研究方法论.
- 手术瘤学手术瘤学
- 康复医学是康复的医学.
背景情况:
- 在临床试验中报告不足会阻碍解释,元分析和知识翻译.
- 预康复干预的目的是改善外科手术候选人,但他们的报告质量没有得到检查.
- 本研究通过评估预康复随机对照试验 (RCT) 的报告标准来弥补这一差距.
研究的目的:
- 评估预康复干预的RCT在多大程度上遵守已建立的方法和干预报告准则.
- 确定预康复试验特征报告中的强项和弱项的具体领域.
- 为改善未来预康复研究报告质量的基础.
主要方法:
- 通过系统搜索,在多个数据库 (MEDLINE,Embase等) 中确定了预康复干预的RCT. 在2022年3月.
- 包括的研究与报告检查清单进行了评估:CONSORT,CERT,修改CERT,TIDieR,PRESENT和CONSORT-SPI.
- 计算了协议比率 (AR),以量化正确报告的指南项目比例.
主要成果:
- 分析了1994年至2022年间发表的70个预康复RCT.
- 仅限于运动的干预 (57%) 和瘤前手术应用 (46%) 是最常见的.
- 所有指南的总体平均同意率 (AR) 为57%,表明报告了大约一半的推项目.
结论:
- 现有的预康复RCT仅报告了当前方法和干预报告准则推的一半的项目.
- 在遵守特定指南方面存在显著的变化,PRESENT (78%) 和CONSORT (71%) 显示较高的AR,而CONSORT-SPI (47%) 和修改CERT (40%) 显示较低的AR.
- 建议制定针对预康复干预措施的量身定制报告检查清单,以提高报告质量并促进研究综合.
更多相关视频
08:54Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
344
05:54A Rehabilitation Program of Exoskeleton-assisted Body Weight-Supported Treadmill Training with Non-immersive Virtual Reality for Stroke Patients
Published on: May 16, 2025
260
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
01:12Hazard Ratio
155
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
155